Results 201 to 210 of about 4,296,132 (289)

[Substandard and falsified medical products: 25 years of successful network collaboration among regulatory authorities in the AmericasProdutos médicos de qualidade inferior e falsificados: 25 anos de colaboração bem-sucedida em rede entre autoridades reguladoras da Região das Américas]. [PDF]

Rev Panam Salud Publica
Vahos Zambrano J, Carrasco G, Rojas-Cortés R, Alfonso MJ, Viñas R, Derecho M, Munguía M, Marin D, Castro JL, Pombo-Castro ML.   +9 more
europepmc   +1 more source

Artemisinin resistance threat in Central and West Africa needs holistic action. [PDF]

J Public Health Afr
Kojom Foko LP, Sharma A.
europepmc   +1 more source

'Prevalence, experience and awareness of substandard and falsified medicines among the public and healthcare professionals in Jordan'. [PDF]

BMJ Glob Health
Falah MM, Daar E, Zahra D, Dillon MJ.
europepmc   +1 more source

Actor-network and stakeholder analysis in preventing health goods smuggling in Iran. [PDF]

Global Health
Meymand FM, Takian A, Jaafaripooyan E.
europepmc   +1 more source

Exploring the Motivations and the Concerns Behind Self-Managed Medication Abortion Done by Purchasing Medication Online: Qualitative Interview Study With US Abortion Seekers Post-Roe.

J Med Internet Res
Bosco C, Otenen E, Shih PC.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Monitoring Counterfeit Drugs using CounterChain

2019 International Conference on Advances in Computing, Communication and Control (ICAC3), 2019
With the advent of globalisation, the average Indian consumer now has the option to shop for a wide range of products across multiple channels. However, with this increase in product choices, one of the significant issues confronted by the industry today is the proliferation of counterfeit drugs in the marketplace. Drug, being a product which is widely
Mihir Chitre, Shubham Sapkal, Afi Adhikari, Shainila Mulla   +3 more
openaire   +2 more sources

System to Fight Counterfeit Drugs

2020
The issue of counterfeit drugs is prevalent worldwide. Developing countries are particularly affected by this problem. The financial loss incurred due to counterfeit drugs is in billions. The main reason for this distribution of counterfeit drugs is the current fragmented supply chain system in pharmaceutical industry.
Soham Tendulkar, Alban Rodrigues, Keval Patel, Harshal Dalvi   +3 more
openaire   +2 more sources

Blockchain Medledger: A Hyperledger Fabric Enabled Drug Traceability System for Counterfeit Drugs in Pharmaceutical Industry.

International journal of pharmaceutics, 2021
Counterfeit drugs are one of the most severe threats to the pharmaceutical industry. World Health Organization (WHO) highlights that nearly 10-35% of the drugs, i.e., one out of ten medicines produced in the least developing countries, are counterfeit ...
Mueen Uddin
semanticscholar   +1 more source

Reducing Counterfeit Drugs with Blockchains: A Survey

2021 International Conference on Information Technology (ICIT), 2021
Blockchain (BC) technology has revealed unusual opportunities to reduce fraud in the pharmaceutical, food and electrical equipment’s, industries.
Abdullah Quzmar, Mohammad Qatawneh, Sarah Al-Maaitah   +2 more
semanticscholar   +1 more source

Drug counterfeiting and decentralized whistleblowers

Drug Discovery Today, 2022
To tackle the devastating issue of drug counterfeiting, the US Food and Drug Administration (FDA) has initiated a pilot project in which 24 companies in the pharmaceutical supply chain use blockchain technology to track and trace drug deliveries among manufacturers, distributors, hospitals, clinics, and pharmacies.
Hossein, Omidian, Yadollah, Omidi
openaire   +2 more sources